Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

ALKS 58.88 +1.20 (2.08%)
price chart
Alkermes Plc Given Average Rating of "Buy" by Analysts (NASDAQ:ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) has been given a consensus recommendation of �Buy� by the seven brokerages that are presently covering the stock, Analyst Ratings.
Related articles »  
Citigroup Inc. Reiterates Buy Rating for Alkermes Plc (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS)'s stock had its �buy� rating restated by research analysts at Citigroup Inc. in a report released on Wednesday.
Alkermes Plc Receives Consensus Rating of "Buy" from Analysts ...  Ticker Report
Related articles »  
Alkermes Plc Stock Rating Reaffirmed by Citigroup Inc. (ALKS)
Alkermes Plc logo Citigroup Inc. restated their buy rating on shares of Alkermes Plc (NASDAQ:ALKS) in a research note issued to investors on Wednesday.
Thursday Hot Stocks: GoPro, Inc. (GPRO), Alkermes plc (ALKS ...  WallStreet Scope
Related articles »  
Is Alkermes plc Stock Undervalued?
In simple terms, what Alkermes plc (NASDAQ: ALKS ) is attempting to do is not easy. Few companies manage to successfully transition from being a licensor of drug formulation technologies to a proprietary drug developer and likewise few independent ...
Insider Selling: Richard F. Pops Sells 100000 Shares of Alkermes Plc Stock ...
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) CEO Richard F. Pops sold 100,000 shares of the company's stock in a transaction dated Thursday, December 11th.
Related articles »  
Alkermes Plc Price Target Raised to $72.00 (ALKS)
Alkermes Plc (NASDAQ:ALKS) traded up 5.94% during mid-day trading on Wednesday, hitting $55.45. The stock had a trading volume of 354,943 shares.
Alkermes Plc PT Raised to $72.00 (ALKS)  Intercooler
Investors Should Watch: Alkermes plc (NASDAQ:ALKS), Minerals Technologies ...  Property Mentor
Related articles »  
Alkermes plc Reports Second Quarter 2014 Financial Results
DUBLIN, Jul 31, 2014 (BUSINESS WIRE) -- Alkermes plc ALKS, +2.72% today reported financial results for the second quarter of 2014.
Alkermes' (ALKS) CEO Richard Pops on Q2 2014 Results - Earnings Call ...  Seeking Alpha (registration)
Related articles »  
Alkermes Plc CEO Richard F. Pops Sells 100000 Shares (ALKS)
Receive News & Ratings for Alkermes Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.
Insider Selling: Michael J. Landine Unloads 18000 Shares of Alkermes Plc ...  Ticker Report
Alkermes Plc SVP Michael J. Landine Unloads 18000 Shares (ALKS)  Mideast Time
Related articles »  
Alkermes Plc CEO Richard F. Pops Unloads 100000 Shares (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) CEO Richard F. Pops sold 100,000 shares of Alkermes Plc stock on the open market in a transaction dated Thursday, November 13th.
Alkermes plc (ALKS) NDA for Aripiprazole Lauroxil Accepted by FDA
Alkermes plc (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for aripiprazole lauroxil, the company's investigational, novel, once-monthly injectable atypical ...
Alkermes' New Drug Application for Aripiprazole Lauroxil for Treatment ...  Business Wire (press release)
Related articles »